| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
5.48(M) |
| Last
Volume: |
4,769,812 |
Avg
Vol: |
4,731,402 |
| 52
Week Range: |
$0.2598 - $0.2598 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
39,883 |
139,755 |
| Total Buy Value |
$0 |
$0 |
$53,107 |
$234,891 |
| Total People Bought |
0 |
0 |
5 |
6 |
| Total Buy Transactions |
0 |
0 |
6 |
22 |
| Total Shares Sold |
0 |
0 |
0 |
2,068 |
| Total Sell Value |
$0 |
$0 |
$0 |
$4,053 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hawkins Richard J |
|
– • – |
2024-09-13 |
4 |
B |
$1.50 |
$5,996 |
D/D |
4,000 |
15,188 |
0.01 |
- |
|
| Hawkins Richard J |
|
– • – |
2024-09-12 |
4 |
B |
$1.35 |
$8,512 |
D/D |
6,285 |
11,188 |
0.01 |
- |
|
| Petersen Greg |
|
– • – |
2024-09-11 |
4 |
B |
$1.35 |
$16,875 |
D/D |
12,500 |
48,921 |
0.01 |
- |
|
| Clowes Howard |
|
– • – |
2024-09-11 |
4 |
B |
$1.34 |
$6,681 |
D/D |
5,000 |
26,497 |
0.01 |
- |
|
| Hedrick Marc H |
Chief Executive Officer |
• • – |
2024-09-10 |
4 |
B |
$1.23 |
$9,839 |
D/D |
8,000 |
20,425 |
0.01 |
- |
|
| Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
• – – |
2024-09-10 |
4 |
B |
$1.27 |
$5,204 |
D/D |
4,098 |
9,815 |
0.01 |
- |
|
| Clowes Howard |
|
– • – |
2024-05-08 |
4 |
B |
$2.04 |
$20,000 |
D/D |
9,804 |
21,497 |
0.01 |
-100% |
|
| Hedrick Marc H |
Chief Executive Officer |
• • – |
2024-05-08 |
4 |
B |
$2.04 |
$25,000 |
D/D |
12,255 |
12,425 |
0.01 |
-100% |
|
| Hawkins Richard J |
|
– • – |
2024-05-08 |
4 |
B |
$2.04 |
$10,000 |
D/D |
4,902 |
4,903 |
0.01 |
-100% |
|
| Lenk Robert P |
|
– • – |
2024-05-08 |
4 |
B |
$2.04 |
$8,501 |
D/D |
4,167 |
29,327 |
0.01 |
-100% |
|
| Petersen Greg |
|
– • – |
2024-05-08 |
4 |
B |
$2.04 |
$25,000 |
D/D |
12,255 |
36,421 |
0.01 |
-100% |
|
| Sims Andrew John Hugh Macintyre |
Chief Financial Officer |
• – – |
2024-05-08 |
4 |
B |
$2.04 |
$10,000 |
D/D |
4,902 |
5,717 |
0.01 |
-100% |
|
| Hedrick Marc H |
Chief Executive Officer |
• • – |
2023-11-20 |
4 |
S |
$1.96 |
$4,053 |
D/D |
(2,068) |
170 |
|
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-16 |
4 |
B |
$1.95 |
$1,950 |
D/D |
1,000 |
25,160 |
2.31 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-15 |
4 |
B |
$1.77 |
$1,770 |
D/D |
1,000 |
24,160 |
2.31 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-13 |
4 |
B |
$1.43 |
$5,720 |
D/D |
4,000 |
23,160 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-10 |
4 |
B |
$1.45 |
$2,900 |
D/D |
2,000 |
19,160 |
2.31 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-09 |
4 |
B |
$1.59 |
$6,676 |
D/D |
4,199 |
17,160 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-08 |
4 |
B |
$1.65 |
$8,250 |
D/D |
5,000 |
12,961 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-07 |
4 |
B |
$1.64 |
$9,840 |
D/D |
6,000 |
7,961 |
2.39 |
- |
|
| Lenk Robert P |
Director |
– • – |
2023-11-06 |
4 |
B |
$1.50 |
$2,093 |
D/D |
1,395 |
1,961 |
2.31 |
- |
|
| Clowes Howard |
Director |
– • – |
2023-09-13 |
4 |
B |
$1.43 |
$10,022 |
D/D |
6,993 |
11,693 |
2.39 |
- |
|
| Petersen Greg |
Director |
– • – |
2023-09-11 |
4 |
B |
$1.70 |
$34,062 |
D/D |
20,000 |
24,166 |
2.39 |
- |
|
| Clowes Howard |
Director |
– • – |
2023-06-06 |
4 |
B |
$3.98 |
$3,980 |
D/D |
1,000 |
4,700 |
2.31 |
- |
|
| Clowes Howard |
Director |
– • – |
2023-05-03 |
4 |
B |
$3.64 |
$9,102 |
D/D |
2,500 |
3,700 |
2.39 |
- |
|
94 Records found
|
|
Page 1 of 4 |
|
|
